OACCU
Oaktree Acquisition Corp. III Life Sciences UnitKey Statistics
About Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) is a specialized acquisition company focused on merging with innovative businesses within the life sciences sector. Leveraging the expertise of a seasoned management team, OACCU aims to tackle critical healthcare challenges by investing in high-potential companies across pharmaceuticals, biotechnology, and medical technology. With a strategic focus on the dynamic life sciences landscape, OACCU is dedicated to creating shareholder value by fostering innovation, improving patient outcomes, and enhancing healthcare management solutions.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.38% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.29 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -16.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $18.46M |
| % Insiders | 3.04% |
| % Institutions | 15.14% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on OACCU and any ticker you trade — then tracks every position and per-strategy win rate.